Long-term protection against varicella with two-dose combination measles-mumps-rubella-varicella vaccine

Affiliations

Comment

Kristine Macartney. Lancet Infect Dis. 2019 Mar.

. 2019 Mar;19(3):222-223.

doi: 10.1016/S1473-3099(18)30797-7. Epub 2019 Feb 11.

¹ National Centre for Immunisation Research and Surveillance, Westmead, NSW 2145, Australia. Electronic address: kristine.macartney@health.nsw.gov.au.

No abstract available

Comment on

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial.
Povey M, Henry O, Riise Bergsaker MA, Chlibek R, Esposito S, Flodmark CE, Gothefors L, Man S, Silfverdal SA, Štefkovičová M, Usonis V, Wysocki J, Gillard P, Prymula R. Povey M, et al. Lancet Infect Dis. 2019 Mar;19(3):287-297. doi: 10.1016/S1473-3099(18)30716-3. Epub 2019 Feb 11. Lancet Infect Dis. 2019. PMID: 30765242 Clinical Trial.